Inventor · disambiguated record
Manoranjan Panda
Also filed as: PANDA MANORANJAN
16 granted patents·8 pending applications·9 citations·filing 2016–2025
86Inventor score
Top patents by PatentIndex Score
24 records- 0187US11267811B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 8, 2022·4 cites·20 claims
- 0285US2024327390A1Substituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0380US11072626B2Small molecule inhibitors of Galectin-3BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 27, 2021·3 cites·20 claims
- 0479US2023124468A1Substituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0576US10501449B2Substituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 10, 2019·1 cites·61 claims
- 0676US2025163046A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0776US2025154148A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0873US10611776B2Spiroheptane salicylamides and related compounds as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 7, 2020·1 cites·17 claims
- 0972USRE49700ESubstituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Oct 17, 2023·0 cites·61 claims
- 1070US2020339550A1Substituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1170US2020109135A1Substituted nitrogen containing compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1268US2025250271A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1364US2024199584A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1459US11639353B2Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted May 2, 2023·0 cites·14 claims
- 1558US10829501B2Spiroheptane salicylamides and related compounds as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 10, 2020·0 cites·5 claims
- 1656US12275720B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB·Filed 2021·Granted Apr 15, 2025·0 cites·13 claims
- 1753US12286424B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB CO·Filed 2021·Granted Apr 29, 2025·0 cites·19 claims
- 1853US12269819B2Small molecule inhibitors of Galectin-3BRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 8, 2025·0 cites·13 claims
- 1952US11014922B2Cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 25, 2021·0 cites·12 claims
- 2048US11970511B2Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 30, 2024·0 cites·23 claims
- 2146US12473304B2Heterocyclic PAD4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 18, 2025·0 cites·29 claims
- 2240US10723723B2Substituted bicycle heterocyclic derivatives useful as ROMK channel inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 28, 2020·0 cites·14 claims
- 2337US10221129B2Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2016·Granted Mar 5, 2019·0 cites·20 claims
- 2435US10851108B2Substituted bicyclic heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 1, 2020·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Manoranjan Panda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →